Pentoxifylline, a medicine used for improving the circulation, has been reported to inhibit TNF-α production and to ameliorate inflammatory bowel disease and non-alcoholic steatohepatitis. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.